Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.

Vijayakrishnan J, Studd J, Broderick P, Kinnersley B, Holroyd A, Law PJ, Kumar R, Allan JM, Harrison CJ, Moorman AV, Vora A, Roman E, Rachakonda S, Kinsey SE, Sheridan E, Thompson PD, Irving JA, Koehler R, Hoffmann P, Nöthen MM, Heilmann-Heimbach S, Jöckel KH, Easton DF, Pharaoh PDP, Dunning AM, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N; PRACTICAL consortium, Greaves M, Zimmerman M, Bartram CR, Schrappe M, Stanulla M, Hemminki K, Houlston RS.

Nat Commun. 2019 Jan 21;10(1):419. doi: 10.1038/s41467-018-08106-9.

2.

Long-term survival after childhood acute lymphoblastic leukaemia: population-based trends in cure and relapse by clinical characteristics.

Smith L, Glaser AW, Kinsey SE, Greenwood DC, Chilton L, Moorman AV, Feltbower RG.

Br J Haematol. 2018 Sep;182(6):851-858. doi: 10.1111/bjh.15424. Epub 2018 May 29.

3.

Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer.

Hassan H, Rompola M, Glaser AW, Kinsey SE, Phillips RS.

Support Care Cancer. 2018 Aug;26(8):2503-2509. doi: 10.1007/s00520-018-4216-z. Epub 2018 Apr 27.

PMID:
29704110
4.

Validation of a classification system for treatment-related mortality in children with cancer.

Hassan H, Rompola M, Glaser AW, Kinsey SE, Phillips RS.

BMJ Paediatr Open. 2017 Oct 30;1(1):e000082. doi: 10.1136/bmjpo-2017-000082. eCollection 2017.

5.

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.

Vijayakrishnan J, Studd J, Broderick P, Kinnersley B, Holroyd A, Law PJ, Kumar R, Allan JM, Harrison CJ, Moorman AV, Vora A, Roman E, Rachakonda S, Kinsey SE, Sheridan E, Thompson PD, Irving JA, Koehler R, Hoffmann P, Nöthen MM, Heilmann-Heimbach S, Jöckel KH, Easton DF, Pharaoh PDP, Dunning AM, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N; PRACTICAL Consortium, Greaves M, Zimmerman M, Bartram CR, Schrappe M, Stanulla M, Hemminki K, Houlston RS.

Nat Commun. 2018 Apr 9;9(1):1340. doi: 10.1038/s41467-018-03178-z. Erratum in: Nat Commun. 2019 Jan 21;10(1):419.

6.

Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK.

Fairley L, Stark DP, Yeomanson D, Kinsey SE, Glaser AW, Picton SV, Evans L, Feltbower RG.

BMC Cancer. 2017 Mar 4;17(1):168. doi: 10.1186/s12885-017-3160-5.

7.

A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.

Vijayakrishnan J, Kumar R, Henrion MY, Moorman AV, Rachakonda PS, Hosen I, da Silva Filho MI, Holroyd A, Dobbins SE, Koehler R, Thomsen H, Irving JA, Allan JM, Lightfoot T, Roman E, Kinsey SE, Sheridan E, Thompson PD, Hoffmann P, Nöthen MM, Heilmann-Heimbach S, Jöckel KH, Greaves M, Harrison CJ, Bartram CR, Schrappe M, Stanulla M, Hemminki K, Houlston RS.

Leukemia. 2017 Mar;31(3):573-579. doi: 10.1038/leu.2016.271. Epub 2016 Oct 3.

8.

The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.

Vijayakrishnan J, Henrion M, Moorman AV, Fiege B, Kumar R, da Silva Filho MI, Holroyd A, Koehler R, Thomsen H, Irving JA, Allan JM, Lightfoot T, Roman E, Kinsey SE, Sheridan E, Thompson PD, Hoffmann P, Nöthen MM, Mühleisen TW, Eisele L, Bartram CR, Schrappe M, Greaves M, Hemminki K, Harrison CJ, Stanulla M, Houlston RS.

Sci Rep. 2015 Oct 14;5:15065. doi: 10.1038/srep15065.

9.

Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.

Gabriel AS, Lafta FM, Schwalbe EC, Nakjang S, Cockell SJ, Iliasova A, Enshaei A, Schwab C, Rand V, Clifford SC, Kinsey SE, Mitchell CD, Vora A, Harrison CJ, Moorman AV, Strathdee G.

Epigenetics. 2015;10(8):717-26. doi: 10.1080/15592294.2015.1061174.

10.

Survival of childhood acute lymphoid leukaemia in Yorkshire by clinical trial era, 1990-2011.

van Laar M, Kinsey SE, Feltbower RG.

Br J Haematol. 2015 Oct;171(1):116-9. doi: 10.1111/bjh.13524. Epub 2015 Jun 4.

11.

Population mixing for leukaemia, lymphoma and CNS tumours in teenagers and young adults in England, 1996-2005.

van Laar M, Stark DP, McKinney P, Parslow RC, Kinsey SE, Picton SV, Feltbower RG.

BMC Cancer. 2014 Sep 23;14:698. doi: 10.1186/1471-2407-14-698.

12.

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.

Moorman AV, Enshaei A, Schwab C, Wade R, Chilton L, Elliott A, Richardson S, Hancock J, Kinsey SE, Mitchell CD, Goulden N, Vora A, Harrison CJ.

Blood. 2014 Aug 28;124(9):1434-44. doi: 10.1182/blood-2014-03-562918. Epub 2014 Jun 23.

PMID:
24957142
13.

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.

Migliorini G, Fiege B, Hosking FJ, Ma Y, Kumar R, Sherborne AL, da Silva Filho MI, Vijayakrishnan J, Koehler R, Thomsen H, Irving JA, Allan JM, Lightfoot T, Roman E, Kinsey SE, Sheridan E, Thompson P, Hoffmann P, Nöthen MM, Mühleisen TW, Eisele L, Zimmermann M, Bartram CR, Schrappe M, Greaves M, Stanulla M, Hemminki K, Houlston RS.

Blood. 2013 Nov 7;122(19):3298-307. doi: 10.1182/blood-2013-03-491316. Epub 2013 Aug 30.

PMID:
23996088
14.

First description of seasonality of birth and diagnosis amongst teenagers and young adults with cancer aged 15-24 years in England, 1996-2005.

van Laar M, Kinsey SE, Picton SV, Feltbower RG.

BMC Cancer. 2013 Jul 31;13:365. doi: 10.1186/1471-2407-13-365.

15.

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor.

Enshaei A, Schwab CJ, Konn ZJ, Mitchell CD, Kinsey SE, Wade R, Vora A, Harrison CJ, Moorman AV.

Leukemia. 2013 Nov;27(11):2256-9. doi: 10.1038/leu.2013.136. Epub 2013 May 2. No abstract available.

PMID:
23636228
16.

A systematic review of time to diagnosis in children and young adults with cancer.

Lethaby CD, Picton S, Kinsey SE, Phillips R, van Laar M, Feltbower RG.

Arch Dis Child. 2013 May;98(5):349-55. doi: 10.1136/archdischild-2012-303034. Epub 2013 Mar 9. Review.

PMID:
23476000
17.

Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia.

Enciso-Mora V, Hosking FJ, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Tomlinson IP, Allan JM, Taylor M, Greaves M, Houlston RS.

Leukemia. 2012 Oct;26(10):2212-5. doi: 10.1038/leu.2012.89. Epub 2012 Mar 29.

PMID:
22456626
18.

Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom.

Lightfoot TJ, Johnston WT, Simpson J, Smith AG, Ansell P, Crouch S, Roman E, Kinsey SE.

Eur J Cancer. 2012 Jan;48(2):263-9. doi: 10.1016/j.ejca.2011.10.007.

PMID:
22206862
19.

Survival trends of cancer amongst the south Asian and non-south Asian population under 30 years of age in Yorkshire, UK.

van Laar M, McKinney PA, Stark DP, Glaser A, Kinsey SE, Lewis IJ, Picton SV, Richards M, Norman PD, Feltbower RG.

Cancer Epidemiol. 2012 Feb;36(1):e13-8. doi: 10.1016/j.canep.2011.08.005. Epub 2011 Sep 9.

20.

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.

Ensor HM, Schwab C, Russell LJ, Richards SM, Morrison H, Masic D, Jones L, Kinsey SE, Vora AJ, Mitchell CD, Harrison CJ, Moorman AV.

Blood. 2011 Feb 17;117(7):2129-36. doi: 10.1182/blood-2010-07-297135. Epub 2010 Nov 24. Erratum in: Blood. 2011 May 5;117(18):5009.

PMID:
21106984
21.

MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia.

Hosking FJ, Leslie S, Dilthey A, Moutsianas L, Wang Y, Dobbins SE, Papaemmanuil E, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Taylor M, Greaves M, McVean G, Houlston RS.

Blood. 2011 Feb 3;117(5):1633-40. doi: 10.1182/blood-2010-08-301598. Epub 2010 Nov 8.

PMID:
21059899
22.

Cancer incidence among the south Asian and non-south Asian population under 30 years of age in Yorkshire, UK.

van Laar M, McKinney PA, Parslow RC, Glaser A, Kinsey SE, Lewis IJ, Picton SV, Richards M, Shenton G, Stark D, Norman P, Feltbower RG.

Br J Cancer. 2010 Oct 26;103(9):1448-52. doi: 10.1038/sj.bjc.6605903. Epub 2010 Sep 14. Erratum in: Br J Cancer. 2013 Mar 19;108(5):1223-4.

23.

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, Papaemmanuil E, Bartram CR, Stanulla M, Schrappe M, Gast A, Dobbins SE, Ma Y, Sheridan E, Taylor M, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Moorman AV, Harrison CJ, Tomlinson IP, Richards S, Zimmermann M, Szalai C, Semsei AF, Erdelyi DJ, Krajinovic M, Sinnett D, Healy J, Gonzalez Neira A, Kawamata N, Ogawa S, Koeffler HP, Hemminki K, Greaves M, Houlston RS.

Nat Genet. 2010 Jun;42(6):492-4. doi: 10.1038/ng.585. Epub 2010 May 9.

24.

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.

Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE, Vora A, Mitchell CD, Harrison CJ.

Lancet Oncol. 2010 May;11(5):429-38. doi: 10.1016/S1470-2045(10)70066-8. Epub 2010 Apr 19. Erratum in: Lancet Oncol. 2010 Jun;11(6):516.

PMID:
20409752
25.

Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia risk.

Hosking FJ, Papaemmanuil E, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Taylor M, Tomlinson IP, Greaves M, Houlston RS.

Blood. 2010 Jun 3;115(22):4472-7. doi: 10.1182/blood-2009-09-244483. Epub 2010 Mar 15.

PMID:
20231427
26.

Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.

Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, Sheridan E, Gast A, Kinsey SE, Lightfoot T, Roman E, Taylor M, Pritchard-Jones K, Stanulla M, Schrappe M, Bartram CR, Houlston RS, Kumar R, Hemminki K.

Blood. 2010 Mar 4;115(9):1765-7. doi: 10.1182/blood-2009-09-241513. Epub 2009 Dec 30.

PMID:
20042726
27.

Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.

Krishnan S, Wade R, Moorman AV, Mitchell C, Kinsey SE, Eden TO, Parker C, Vora A, Richards S, Saha V.

Leukemia. 2010 Feb;24(2):450-9. doi: 10.1038/leu.2009.264. Epub 2009 Dec 17.

28.

Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.

Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Tomlinson IP, Taylor M, Greaves M, Houlston RS.

Nat Genet. 2009 Sep;41(9):1006-10. doi: 10.1038/ng.430. Epub 2009 Aug 16.

29.

Epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002.

Feltbower RG, McNally RJ, Kinsey SE, Lewis IJ, Picton SV, Proctor SJ, Richards M, Shenton G, Skinner R, Stark DP, Vormoor J, Windebank KP, McKinney PA.

Eur J Cancer. 2009 Feb;45(3):420-7. doi: 10.1016/j.ejca.2008.09.020. Epub 2008 Nov 12.

PMID:
19004628
30.

The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report.

Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K.

Support Cancer Ther. 2006 Jul 1;3(4):220-31. doi: 10.3816/SCT.2006.n.020.

PMID:
18632498
31.

High loading dose AmBisome is efficacious and well tolerated in the management of invasive fungal infection in hematology patients.

McLintock LA, Cook G, Holyoake TL, Jones BL, Kinsey SE, Jackson GH.

Haematologica. 2007 Apr;92(4):572-3.

32.

Allergy and risk of childhood leukaemia: results from the UKCCS.

Hughes AM, Lightfoot T, Simpson J, Ansell P, McKinney PA, Kinsey SE, Mitchell CD, Eden TO, Greaves M, Roman E; United Kingdom Childhood Cancer Study Investigators.

Int J Cancer. 2007 Aug 15;121(4):819-24.

33.

Survival following relapse in childhood haematological malignancies diagnosed in 1974-2003 in Yorkshire, UK.

Feltbower RG, Kinsey SE, Richards M, Shenton G, Michelagnoli MP, McKinney PA.

Br J Cancer. 2007 Apr 10;96(7):1147-52. Epub 2007 Mar 6.

34.

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).

Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BE, Kinsey SE, Eden TO, Vora AJ, Mitchell CD, Harrison CJ; UK Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Childhood Leukaemia Working Party (CLWP).

Blood. 2007 Mar 15;109(6):2327-30. Epub 2006 Nov 9.

PMID:
17095619
35.

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.

Vora A, Mitchell CD, Lennard L, Eden TO, Kinsey SE, Lilleyman J, Richards SM; Medical Research Council; National Cancer Research Network Childhood Leukaemia Working Party.

Lancet. 2006 Oct 14;368(9544):1339-48.

PMID:
17046466
36.

The investigation and management of chronic neutropenia in children.

James RM, Kinsey SE.

Arch Dis Child. 2006 Oct;91(10):852-8. Review.

37.

Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow.

Jones EA, English A, Kinsey SE, Straszynski L, Emery P, Ponchel F, McGonagle D.

Cytometry B Clin Cytom. 2006 Nov 15;70(6):391-9.

38.

Successful recovery of aplastic anemia following orthotopic liver transplantation for non-A-E acute liver failure.

Rajwal SR, Davison SM, Stringer MD, Kinsey SE, McClean P.

Pediatr Transplant. 2005 Aug;9(4):537-40.

PMID:
16048610
39.

Leukemic infiltration of the orbit: report of three cases and literature review.

Taylor CW, Taylor RE, Kinsey SE.

Pediatr Hematol Oncol. 2005 Jul-Aug;22(5):415-22.

PMID:
16020132
40.

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.

Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO; Medical Research Council Childhood Leukaemia Working Party.

Br J Haematol. 2005 Jun;129(6):734-45.

PMID:
15952999
41.

Detecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach.

Feltbower RG, Manda SO, Gilthorpe MS, Greaves MF, Parslow RC, Kinsey SE, Bodansky HJ, McKinney PA.

Am J Epidemiol. 2005 Jun 15;161(12):1168-80.

PMID:
15937026
42.

Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial.

Roy A, Bradburn M, Moorman AV, Burrett J, Love S, Kinsey SE, Mitchell C, Vora A, Eden T, Lilleyman JS, Hann I, Saha V; Medical Research Council Childhood Leukaemia Working Party.

Br J Haematol. 2005 Apr;129(1):35-44.

PMID:
15801953
43.

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.

Harrison CJ, Moorman AV, Broadfield ZJ, Cheung KL, Harris RL, Reza Jalali G, Robinson HM, Barber KE, Richards SM, Mitchell CD, Eden TO, Hann IM, Hill FG, Kinsey SE, Gibson BE, Lilleyman J, Vora A, Goldstone AH, Franklin IM, Durrant J, Martineau M; Childhood and Adult Leukaemia Working Parties.

Br J Haematol. 2004 Jun;125(5):552-9.

PMID:
15147369
44.

Diagnosing childhood cancer in primary care--a realistic expectation?

Feltbower RG, Lewis IJ, Picton S, Richards M, Glaser AW, Kinsey SE, McKinney PA.

Br J Cancer. 2004 May 17;90(10):1882-4.

45.

Geographic mobility following cancer treatment in Yorkshire, UK.

Feltbower RG, Glaser AW, Parslow RC, Kinsey SE.

Arch Dis Child. 2004 Apr;89(4):380-1.

46.

Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis.

Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D.

Arthritis Rheum. 2004 Mar;50(3):817-27.

47.

Non-Hodgkin lymphoma presenting with obstructive jaundice.

Ravindra KV, Stringer MD, Prasad KR, Kinsey SE, Lodge JP.

Br J Surg. 2003 Jul;90(7):845-9.

PMID:
12854111
48.

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.

Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR, Broadfield ZJ, Harris RL, Taylor KE, Gibson BE, Hann IM, Hill FG, Kinsey SE, Eden TO, Mitchell CD, Harrison CJ; United Kingdom Medical Research Council's Childhood Leukemia Working Party.

Blood. 2003 Oct 15;102(8):2756-62. Epub 2003 Jun 26.

PMID:
12829593
49.

Intraocular relapse of childhood acute lymphoblastic leukaemia.

Somervaille TC, Hann IM, Harrison G, Eden TO, Gibson BE, Hill FG, Mitchell C, Kinsey SE, Vora AJ, Lilleyman JS; MRC Childhood Leukaemia Working Party.

Br J Haematol. 2003 Apr;121(2):280-8.

PMID:
12694250
50.

Management of infection in children with malignancy.

Miflin G, Kinsey SE.

Eur J Cancer. 2003 Mar;39(5):644-51. Review. No abstract available.

PMID:
12628844

Supplemental Content

Loading ...
Support Center